Addex Therapeutics Ltd - American Depositary Shares (ADXN)
2.8500
+0.0400 (1.42%)
NASDAQ · Last Trade: Sep 29th, 11:41 AM EDT
Detailed Quote
Previous Close
2.810
Open
2.740
Bid
2.830
Ask
3.160
Day's Range
2.690 - 2.970
52 Week Range
2.560 - 11.97
Volume
27,992
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
38,951
Chart
About Addex Therapeutics Ltd - American Depositary Shares (ADXN)
Addex Therapeutics Ltd is a biopharmaceutical company focused on developing innovative treatments for neurological and psychiatric disorders. The company leverages its expertise in allosteric modulation to identify and develop novel therapies aimed at a variety of conditions, including addiction, anxiety, and epilepsy. By utilizing its proprietary technology platform, Addex works to create safer and more effective therapeutic options that can enhance patient outcomes and address unmet medical needs in the complex field of brain health. Read More
Addex Therapeutics (NASDAQ:ADXN) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. Benzinga APIs provide real-time access to
